Thursday, 27 February 2020

China News

  • AZ, WuXi enter first-of-its-kind biotech deal in China

    China |  News | By BioSpectrum Bureau  | 0 Comment | 14 Sep, 2012

    Singapore: AstraZeneca has established a joint venture (JV) with WuXi AppTec, China, to develop a new biotech medicine. Under the terms of the deal, WuXi will supply all local regulatory, m...Read more

  • BGI-Shenzhen extends tender offer for Complete

    China |  News | By BioSpectrum Bureau  | 0 Comment | 04 Feb, 2013

    Singapore: BGI-Shenzhen (BGI) announced that its wholly-owned subsidiary Beta Acquisition, has extended its all cash tender offer to purchase all outstanding shares of common stock of Comp...Read more

  • What functional roles do CROs play in APAC?

    China |  Analysis | By BioSpectrum Bureau  | 0 Comment | 18 Sep, 2013

    The fifth edition of the annual BioSpectrum Asia Pacific clinical research organization (CRO) Survey, which is conducted in association with CyberMedia Research (CMR), yet again identifie...Read more

  • China flu outbreak spooks Tibet, Sri Lanka

    China |  News | By BioSpectrum Bureau  | 0 Comment | 16 May, 2013

    Singapore: The Tibetan Ministry of Agriculture revealed on Tuesday, May 14, 2013, that a fresh outbreak of the older strain of H5N1 bird flu was reported from a remote part. This highly con...Read more

  • Bayer confirms probe by Chinese antitrust officials

    China |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2014

    Singapore: Issuing a statement to the media confirming a probe at its Chinese offices, German drug giant Bayer has now said that it is cooperating with the authorities. Bayer AG is the lat...Read more

  • Huahai, Oncobiologics enter generics partnership

    China |  News | By BioSpectrum Bureau  | 0 Comment | 10 May, 2013

    Singapore: US-based Oncobiologics has signed an alliance agreement with China-based Zhejiang Huahai Pharmaceutical for the development, manufacture and commercialization of biosimilar monoc...Read more

  • BMS gives $1.69 Mn hepatitis grant to India and China

    China |  News | By BioSpectrum Bureau  | 0 Comment | 27 Jul, 2012

    Singapore: The Bristol-Myers Squibb Foundation has awarded four new grants totaling $1.69 million to improve prevention, care and support of hepatitis B (HBV) and hepatitis C (HCV) in China...Read more

  • Fosun Pharma buys laser medtech firm for $240 mn

    China |  News | By BioSpectrum Bureau  | 0 Comment | 30 Apr, 2013

    ‎Singapore: Shanghai-based Fosun Pharmaceutical, along with Pramerica-Fosun Fund, is acquiring a 95.6 percent stake in Israel-based Alma Lasers for $240 million. The company's first ...Read more

  • Bulgaria-China spur bilateral cooperation

    China |  News | By BioSpectrum Bureau  | 0 Comment | 18 Sep, 2013

    Singapore: Bulgaria and China held a trade and cooperation event on pharmaceuticals and medical devices, aimed at the development of bilateral ties in this industry, in Sofia, Bulgaria, acc...Read more

  • Industry Records 11% Growth

    China |  Analysis | By BioSpectrum Bureau  | 0 Comment | 22 Jun, 2015

    Singapore: The bioscience industry in the major markets of Asia-Pacific region, excluding Japan and comprising Australia, China, India, South Korea, Malaysia, Singapore, and Taiwan recorded...Read more

  • China National Biotec, Riboxx ink collaboration

    China |  News | By BioSpectrum Bureau  | 0 Comment | 06 Mar, 2013

    Singapore: Germany's Riboxx Pharmaceuticals and China National Biotec Group (CNBG) have initiated a research collaboration to evaluate Riboxxim, a TLR3 agonist from Riboxx, with an antigen ...Read more

  • BSA-CMR Survey: New CRO players emerge in APAC

    China |  Analysis | By BioSpectrum Bureau  | 0 Comment | 18 Sep, 2013

    The fifth edition of the annual BioSpectrum Asia Pacific clinical research organization (CRO) Survey, which is conducted in association with CyberMedia Research (CMR), yet again identifie...Read more

  • Nose cancer emerges as a potent killer in Asia

    China |  Analysis | By BioSpectrum Bureau  | 0 Comment | 19 Sep, 2013

    Singapore: Nasopharyngeal carcinoma (NPC) is a rare form of cancer in Western Europe and North America and is emerging as a leading cancer in Southern China and South East Asia, according t...Read more

  • UN: Child deaths down by half since 1990

    China |  News | By BioSpectrum Bureau  | 0 Comment | 16 Sep, 2013

    Singapore: In 2012, approximately 6.6 million children worldwide, died at the rate of 18,000 per day before reaching their fifth birthday, according to a new report released by UNICEF, WHO,...Read more

  • Alchemia gets US patent for oncology platform technology

    China |  News | By BioSpectrum Bureau  | 0 Comment | 06 Mar, 2013

    Singapore: Brisbane-based drug discovery and development company Alchemia has been granted a key US patent critical to its platform oncology technology. The patent is being regarded as a ...Read more

  • China National Accord's R&D strategy begins to pay-off

    China |  Analysis | By BioSpectrum Bureau  | 0 Comment | 31 May, 2013

    China National Accord Medicines Corporation utilized 2012 as a year to speed up the transformation and upgrade scientific development by implementing new medical reforms fostered by Chine...Read more

  • Celgene gets approval for Revlimid in China

    China |  News | By BioSpectrum Bureau  | 0 Comment | 12 Feb, 2013

    Singapore: Celgene has been granted full approval, which includes an Import Drug License by the China State Food and Drug Administration (SFDA) for use of Revlimid (lenalidomide) in combina...Read more

  • US Justice Department probing GSK again

    China |  News | By BioSpectrum Bureau  | 0 Comment | 10 Sep, 2013

    Singapore: GlaxoSmithKline's (GSK) China bribery scandal has now triggered a US Justice Department probe into whether the British drug maker violated any US law, a Reuters news report said....Read more